Small Molecule Inhibitors of Mycobacterium tuberculosis Topoisomerase I Identified by Machine Learning and In Vitro Assays
International Journal of Molecular Sciences · 2024
DOI: 10.3390/ijms252212265 ↗Kurz gefasst
Fachartikel in der Zeitschrift International Journal of Molecular Sciences, 2024. Verfasst von Somaia Haque Chadni und 5 weiteren Autor:innen. Beteiligte Einrichtung: Biochemistry PhD Program, Department of Chemistry and Biochemistry, Florida International University, Miami, FL 33199, USA. Hauptthemen laut MEDLINE: Mycobacterium tuberculosis, Machine Learning, Topoisomerase I Inhibitors, DNA Topoisomerases, Type I. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 50 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NIGMS NIH HHS, NIH HHS, Atomwise Inc..
Abstract (Originalsprache)
Tuberculosis (TB) caused by Mycobacterium tuberculosis is a leading infectious cause of death globally. The treatment of patients becomes much more difficult for the increasingly common multi-drug resistant TB. Topoisomerase I is essential for the viability of M. tuberculosis and has been validated as a new target for the discovery of novel treatment against TB resistant to the currently available drugs. Virtual high-throughput screening based on machine learning was used in this study to identify small molecules that target the binding site of divalent ion near the catalytic tyrosine of M. tuberculosis topoisomerase I. From the virtual screening of more than 2 million commercially available compounds, 96 compounds were selected for testing in topoisomerase I relaxation activity assay. The top hit that has IC50 of 7 µM was further investigated. Commercially available analogs of the top hit were purchased and tested with the in vitro enzyme assay to gain further insights into the molecular scaffold required for topoisomerase inhibition. Results from this project demonstrated that novel small molecule inhibitors of bacterial topoisomerase I can be identified starting with the machine-learning-based virtual screening approach.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Biochemistry PhD Program, Department of Chemistry and Biochemistry, Florida International University, Miami, FL 33199, USA.
- Atomwise Inc., San Francisco, CA 94103, USA.
- Department of Chemistry and Biochemistry, Florida International University, Miami, FL 33199, USA.
- Biomolecular Sciences Institute, Department of Chemistry and Biochemistry, Florida International University, Miami, FL 33199, USA.
ORCID-Profile: Victor Kenyon, Yuk-Ching Tse-Dinh
Förderung
- NIGMS NIH HHS
- NIH HHS
- Atomwise Inc.
- National Institute of General Medical Sciences of the National Institutes of Health
Zitieren
APA
Chadni, S. H., Young, M. A., Igorra, P., Bhuiyan, M. A. R., Kenyon, V., & Tse-Dinh, Y. C. (2024). Small Molecule Inhibitors of Mycobacterium tuberculosis Topoisomerase I Identified by Machine Learning and In Vitro Assays. International Journal of Molecular Sciences. https://doi.org/10.3390/ijms252212265
Vancouver
Chadni SH, Young MA, Igorra P, Bhuiyan MAR, Kenyon V, Tse-Dinh YC. Small Molecule Inhibitors of Mycobacterium tuberculosis Topoisomerase I Identified by Machine Learning and In Vitro Assays. International Journal of Molecular Sciences. 2024. doi:10.3390/ijms252212265
BibTeX
@article{Chadni2024,
author = {Chadni, Somaia Haque and Young, Matthew A and Igorra, Pedro and Bhuiyan, Md Anisur Rahman and Kenyon, Victor and Tse-Dinh, Yuk-Ching},
title = {Small Molecule Inhibitors of Mycobacterium tuberculosis Topoisomerase I Identified by Machine Learning and In Vitro Assays},
journal = {International Journal of Molecular Sciences},
year = {2024},
doi = {10.3390/ijms252212265}
}
EUVIMED